Russian government proposed to increase funding for pharmaceutical industry

Print 13 November 2017
GMP News

The government has proposed to increase funding for the state program “Development of Pharmaceutical and Medical Industry” by 6.38 million rubles in 2018-2020. This results from the amendments to the draft budget prepared for the second reading in the State Duma.

It means that, in 2018, the state may allocate for the program 101.22 million rubles; in 2019, 101.61 million rubles; and in 2020, 101.59 million rubles.

Earlier, Alexey Alekhin, the Head of Pharmaceutical and Medical industry Development Department of the Russian Ministry of Industry and Trade, said that, under the state program “Development of Pharmaceutical and Medical Industry in 2013-2020,” the government provides subsidies to enterprises to compensate for the costs of the development of medicinal products and medical devices, organization of substance manufacturing, and clinical trials.

Source

Return